Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...
an investigational gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). All QUANTI studies investigated gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body ...
Bayer (OTCPK:BAYRY) said that phase 3 data on its experimental MRI contrast agent gadoquatrane met primary and secondary endpoints in phase 3 trials.The QUANTI studies examined gadoquatrane at a ...
The magnetic resonance imaging (MRI) contrast agent – based on gadobutrol – has been cleared by the FDA for cardiac MRIs on the back of two phase 3 trials which showed it was safe and ...
The global contrast media injectors market is on a steady growth trajectory, with revenue projected to rise from USD 4,949 ...
Figure 1: Etoposide-induced apoptosis in EL4 cells analyzed using flow cytometry and DNA gel electrophoresis. Figure 3: MR images of a tumor in a drug-treated mouse following injection of C 2 ...
Dong Kook Lifescience lists on KOSDAQ, aims for 300 billion won by 2030 Dong Kook Lifescience seeks to enhance global ...
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult ...
QUANTI clinical development programme evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and across all ages In the ...
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback